BARTHELEMY NICOLAS

Average Profitability
<0.0001%
Insider Buys Quantity
3
Insider Buys Sum
$680,636.05
Insider Sells Quantity
10
Insider Sells Sum
$6.02M

Insider Activity of BARTHELEMY NICOLAS

According to the SEC Form 4 filings, BARTHELEMY NICOLAS, being in a position of

  1. director at Repligen Corporation,
    оver the last 12 months, has bought 1200 shares for $150,540, and sold 0 shares,
    over all time since 2018-05-09, has bought 1200 shares for $150,540, and sold 70824 shares for $4.21M.

The largest purchase of all time was on 2020-12-22 and amounted to 28000 shares of 908 Devices Inc. for $280,000.

The largest sale of all time was on 2018-05-09 and amounted to 53000 shares of Repligen Corporation for $2.15M.

Biography of BARTHELEMY NICOLAS

No biography is available at this moment.

2024-06-14PurchaseRepligen Corporation
RGEN
director
1,200
0.0019%
$125.45$150,540+13.06%
2022-05-11PurchaseTwist Bioscience Corporation
TWST
8,550
0.0167%
$29.25$250,096+9.24%
2021-10-29SaleRepligen Corporation
RGEN
director
1,645
0.003%
$288.20$474,085-34.62%
2021-06-24Sale908 Devices Inc.
MASS
VP, Corporate Development
8,000
0.0294%
$40.00$320,000-39.79%
2021-06-23Sale908 Devices Inc.
MASS
VP, Corporate Development
18,000
0.0551%
$33.27$598,890-39.61%
2021-02-09SaleTwist Bioscience Corporation
TWST
10,000
0.0102%
$88.80$888,035-37.06%
2020-12-22Purchase908 Devices Inc.
MASS
director
28,000
0.0907%
$10.00$280,000-31.92%
2020-11-09SaleRepligen Corporation
RGEN
director
1,214
0.0023%
$195.51$237,349+7.61%
2020-05-18SaleRepligen Corporation
RGEN
director
3,009
0.006%
$142.53$428,873+31.87%
2020-04-22SaleRepligen Corporation
RGEN
director
2,688
0.005%
$109.99$295,653+52.41%
2020-04-03SaleRepligen Corporation
RGEN
director
2,688
0.0052%
$99.99$268,773+60.27%
2018-08-29SaleRepligen Corporation
RGEN
director
6,580
0.015%
$54.44$358,196+9.53%
2018-05-09SaleRepligen Corporation
RGEN
director
53,000
0.1219%
$40.54$2.15M+37.07%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.